Speaker Biography

Syed Raza

Consultant Cardiologist, Awali Hospital, Bahrain

Title: Heart Failure: Management Failures- Who is to be blamed?

Syed Raza

Dr Syed  Raza  graduated from Aligarh University in India  in 1993. After completing his postgraduate degree in Medicine from the same university, he moved to the UK for higher specialist studies. He successfully completed MRCP and CCT and later also  awarded Fellow of the Royal College of Physicians of Edinburgh. He was awarded professor John Goodwin prize for outstanding performance in Diploma Cardiology exam  at Hammersmith Hospital, University of London in 2001.  Dr  Raza  is  Fellow  of  American  College  of  Cardiology  ,  American  College  of  Chest  Physicoans  as  well  as  Fellow  of  European  Society  of  Cardiology.  He  is  also  on  the  committee  of  Acute  Cardiovascular  Care.  Heart  Failure  and  Cardiovascular  Imaging (  European  Society of  Cardiology )

He is currently serving as  consultant in Cardiology and Head of the department of Medicine  at Awali Hospital, Bahrain. He is the educational coordinator and  chairman of resuscitation  committee of the hospital. He is the regional coordinator  and examiner for  MRCP  exam for the Royal College of Physicians of Edinburgh. He is external examiner for Arabian Gulf Medical  University. He is also the immediate past chairman of Medical Advisory Committee. He has to his credit  numerous publications and he has presented his work in  different parts of the world. He is peer review author for some well respected International  journals.

He is Review author for abstracts for European Society of Cardiology Annual Congress 2018.


Heart failure (HF) remains a major public health problem that has high incidence and prevalence globally.  It is the leading cause of hospitalization for people of 65 years of age and older, and rates of hospital readmission within 6 months range from 25% to 50%. The personal burden of HF includes debilitating symptoms, frequent rehospitalizations, and high rates of mortality. HF also poses a substantial economic burden, with annual direct costs for the care of HF patients estimated to be between $20 billion and $56 billion.

 A number of studies have documented marked variation in the quality of care judged by specific performance measures and substantial underuse of evidence-based, guideline-recommended HF therapies in patients receiving conventional care. Moreover, patient behavioural factors (such as nonadherence to diet and medications) and economic and social factors frequently contribute to rehospitalizations. The traditional model of care delivery is thought to contribute to frequent hospitalizations because in these brief episodic encounters, little attention may be paid to the common modifiable factors that precipitate many hospitalizations. Patient education, discharge plan, follow up and management at community level are variable and sub optimal. Limited or poor patient participation and involvement in self-care is also a major factor in leading to poor outcome in HF.

As such, there has been much interest in identifying effective methods to improve the quality of care for HF patients while reducing costs. An effective management strategy and a balanced approach is the much needed.